FinnCap reissued their corporate rating on shares of OptiBiotix Health (LON:OPTI) in a research report sent to investors on Tuesday.

OptiBiotix Health (LON OPTI) traded down GBX 1.50 ($0.02) during mid-day trading on Tuesday, hitting GBX 64.50 ($0.87). The stock had a trading volume of 104,714 shares, compared to its average volume of 175,032. OptiBiotix Health has a 52 week low of GBX 59 ($0.79) and a 52 week high of GBX 90 ($1.21).

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at

OptiBiotix Health Company Profile

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with's FREE daily email newsletter.